REPRODUCTION
Mdb44-006	Blood Cytokine Profiling Reveals Distinct Inflammatory Signatures in Phenotypes A and B of Polyendocrine Metabolic Ovarian Syndrome (PMOS; formerly PCOS)
	Article:	https://www.medrxiv.org/content/10.64898/2026.10.20.26365978v1
	Search Similar:	Mojeek Startp Brave Bing Googl Lycos Utub Yahoo
	Search Authors:	Lipika Priyadarsini Patra Betcy Susan Johnson K Jayakrishnan Sathy M Pillai Malini Laloraya,
REPRODUCTION
Mge44-006	Genetic Variants Associated with Placental Abnormalities in Stillbirths
	Article:	https://www.medrxiv.org/content/10.64898/2026.10.19.26365933v1
	Search Similar:	Mojeek Startp Brave Bing Googl Lycos Utub Yahoo
	Search Authors:	Tsegaselassie Workalemahu Thomas J. Nicholas Aaron R. Quinlan Xiaoxu Yang Laurie B. Griffin Susannah Leisher Nathan R. Blue Anya L. Arthurs Jessica M. Page D. Ware Branch Nicola J. Camp Lynn B. Jorde Claire T. Roberts Jessica L. Giordano Ronald Wapner John Kingdom Karen J. Gibbins Mana M. Parast Uma M Reddy Robert M. Silver,
REPRODUCTION
Mnu44-003	Beneficial effects of a standardised saffron extract (SafrInsideTM) on premenstrual syndrome: a multicentric, double-blind, randomized, placebo-controlled trial
	Quote:	Conclusions Daily supplementation with saffron extract over three menstrual cycles significantly improved overall PMS symptom severity compared with placebo in women with mild-to-moderate PMS. Benefits were also observed for affective, pain, and water retention symptoms. Saffron extract was well-tolerated and may represent a promising non-pharmacological option for women experiencing bothersome PMS symptoms.
	Article:	https://www.medrxiv.org/content/10.64898/2026.10.19.26365879v1
	Search Similar:	Mojeek Startp Brave Bing Googl Lycos Utub Yahoo
	Search Authors:	Camille Pouchieu Roberta Villa Fabio Amone Line Pourtau Benjamin Moras Vincenzo Nobile,
NUTRITION REPRODUCTION
Mnu44-004	Dietary Enhancement for Iron Deficiency and Anaemia Treatment (DEFeAT): study protocol for a randomised controlled trial to assess the effect of a mineral-enriched powder on iron deficiency in women of reproductive age
	Quote:	Discussion Fortification, an effective approach for the prevention of ID/IDA, has advantages over some methods of supplementation because it uses low levels of iron, minimising unpleasant side effects, does not risk toxicity, and has high acceptability and compliance rates. This mineral-enriched powder uses electrolytic iron and zinc sulphate monohydrate of a small particle size, which is less irritating to the gut, and facilitates bioavailability.
	Article:	https://www.medrxiv.org/content/10.64898/2026.10.20.26365734v1
	Search Similar:	Mojeek Startp Brave Bing Googl Lycos Utub Yahoo
	Search Authors:	Jessie L Burns Hailey Scott Lawrence Mbuagbaw Clara H Miller Hauna Sheyholislami Brianne A Clouthier Bndicte Fontaine-Bisson Kristin L Connor,
REPRODUCTION
Mob44-003	Expression and Distribution of Src Kinase Lyn in the Placenta of Patients with Preeclampsia
	Quote:	We conclude that placental LYN expression is selectively elevated in early-onset PE and correlates with maternal blood pressure severity. Lyn localization to trophoblasts and placental immune cells suggests potential roles in mediating inflammation and hypoxia-associated signaling in PE pathogenesis.... Transcriptomic data showed that LYN was the sole SFK member consistently elevated in early-onset PE placentas across discovery (1.8-fold, FDR0.01) and validation cohorts (2.2-fold, FDR0.001).
	Article:	https://www.medrxiv.org/content/10.64898/2026.10.19.26365934v1
	Search Similar:	Mojeek Startp Brave Bing Googl Lycos Utub Yahoo
	Search Authors:	Taryn D. Heyman Irina A. Buhimschi Guomao Zhao Bani Medegan Fagla Catalin S. Buhimschi William E. Ackerman span classnlm-suffixIV,
REPRODUCTION
Mob44-006	Menstrual symptoms and infertility odds among individuals with co-occurring endometriosis and polyendocrine metabolic ovarian syndrome
	Quote:	Conclusion In this large US digital cohort, co-occurring endometriosis and PMOS affected 1 in 50 participants and was associated with markedly elevated infertility odds exceeding additive expectations, and a heightened menstrual symptom burden. Several risk factors and health impacts characteristic of each condition appeared amplified in individuals with both conditions, suggesting a subgroup with compounded clinical complexity and greater care needs.
	Article:	https://www.medrxiv.org/content/10.64898/2026.10.13.26365449v1
	Search Similar:	Mojeek Startp Brave Bing Googl Lycos Utub Yahoo
	Search Authors:	Sophia Werdin Zifan Wang Eliana Huffman Anne Marie Z Jukic Allen J Wilcox Sanaa Suharwardy Jukka-Pekka Onnela Brent A Coull Michelle A Williams Shruthi Mahalingaiah,
REPRODUCTION
Mph44-008	Risk of extrapyramidal side effects in the newborn after single dose maternal metoclopramide administration prior to cesarean section: an analysis via physiology-based pharmacokinetic and pharmacodynamic modeling
	Quote:	However, predicted population variability indicated that for a small but clinically relevant subset of newborns (#8764; 5 at 24 weeks and #8764;1 at 32 weeks GA, respectively), the 80 D2-receptor occupancy could be exceeded under standard dosing regimens, indicative of EPS risk.
	Article:	https://www.medrxiv.org/content/10.64898/2026.10.08.26365051v1
	Search Similar:	Mojeek Startp Brave Bing Googl Lycos Utub Yahoo
	Search Authors:	Hedwig van Hove Joyce E.M. van der Heijden Petra van den Broek Joris van Drongelen Saskia N. de Wildt Rick Greupink,

Javilk's Research Links Newsletter for Week 45
Updated 11/14/2026-03:15:39 AM
Back Issue Topic Map
What interests you? What have you found? Tell me!
Drop me a note at Javilk.com to subscribe or submit something.

Mdb44-006

Blood Cytokine Profiling Reveals Distinct Inflammatory Signatures in Phenotypes A and B of Polyendocrine Metabolic Ovarian Syndrome (PMOS; formerly PCOS)

Mge44-006

Genetic Variants Associated with Placental Abnormalities in Stillbirths

Mnu44-003

Beneficial effects of a standardised saffron extract (SafrInsideTM) on premenstrual syndrome: a multicentric, double-blind, randomized, placebo-controlled trial

Mnu44-004

Dietary Enhancement for Iron Deficiency and Anaemia Treatment (DEFeAT): study protocol for a randomised controlled trial to assess the effect of a mineral-enriched powder on iron deficiency in women of reproductive age

Mob44-003

Expression and Distribution of Src Kinase Lyn in the Placenta of Patients with Preeclampsia

Mob44-006

Menstrual symptoms and infertility odds among individuals with co-occurring endometriosis and polyendocrine metabolic ovarian syndrome

Mph44-008

Risk of extrapyramidal side effects in the newborn after single dose maternal metoclopramide administration prior to cesarean section: an analysis via physiology-based pharmacokinetic and pharmacodynamic modeling